Bond Screener
Harrow
LEI 529900AP4LIRLNV8A089
Organization name
Harrow, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
285 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Harrow Health, Inc. is an ophthalmology-focused pharmaceutical company specialized in the development, production and sale of innovative medications that offer unique competitive advantages and serve unmet needs in the marketplace.
|
General information
-
Organization nameHarrow, Inc.
-
Organization statusOperating organization
-
Address1A Burton Hills Blvd., Suite 200, Nashville, USA, 37215
News
-
Harrow: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits04/09/2026
-
Harrow: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits03/08/2026
-
Harrow: Submission Of Matters To A Vote Of Security Holders18/06/2026
-
Harrow Health (NASDAQ:HROW) Maintains "Buy" Rating and Showcases Growth in Ophthalmic Sector24/03/2026
-
Harrow: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits30/01/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameHarrow, Inc.
-
Organization statusOperating organization
-
Address1A Burton Hills Blvd., Suite 200, Nashville, USA, 37215
Codes
-
LEI529900AP4LIRLNV8A089
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001360214
-
EIN45-0567010
